Hess Michael W, Make Barry
Battle Creek Veterans Administration Medical Center, Battle Creek, Michigan.
National Jewish Health, Denver, Colorado.
Chronic Obstr Pulm Dis. 2016 Jan 15;3(1):473-478. doi: 10.15326/jcopdf.3.1.2015.0173.
The treatment and management of chronic obstructive pulmonary disease (COPD) have gone through significant changes over the past decade. This plenary session, part of the 2015 COPD9USA conference, examines how the diagnosis and management of COPD has become more individualized as new phenotypes have been identified. In addition, new diagnostic and management tools are evaluated and the importance of including the patient perspective when designing a treatment plan is discussed. Finally, the future integration of technology in research, clinical communication, and disease education is introduced, including how the COPD Foundation is encouraging and facilitating these efforts. This article serves as a CME available enduring material summary of the following COPD9 presentations: "The Past and Present Evidence" : Stephen Rennard, MD "COPD: The Way Forward" : Gerard Turino, MD "E-Cigarettes-Hope, Hype or Danger?" Russell Bowler, MD, PhD "Looking Forward" Prescott Woodruff, MD "The Future is Now: A Patient Perspective" : Jim Nelson "COPD360 & The Patient-Powered Research Network" John Walsh.
在过去十年中，慢性阻塞性肺疾病（COPD）的治疗与管理发生了重大变化。本次全会是2015年美国慢性阻塞性肺疾病大会的一部分，探讨了随着新的表型被识别，慢性阻塞性肺疾病的诊断与管理如何变得更加个体化。此外，还评估了新的诊断和管理工具，并讨论了在设计治疗方案时纳入患者观点的重要性。最后，介绍了技术在研究、临床沟通和疾病教育方面的未来整合情况，包括慢性阻塞性肺疾病基金会如何鼓励和推动这些工作。本文是以下慢性阻塞性肺疾病相关演讲的继续医学教育（CME）可用持久材料总结：“过去与现在的证据”：医学博士斯蒂芬·伦纳德；“慢性阻塞性肺疾病：前进之路”：医学博士杰勒德·图里诺；“电子烟——希望、炒作还是危险？”：医学博士、哲学博士拉塞尔·鲍勒；“展望未来”：医学博士普雷斯科特·伍德拉夫；“未来已来：患者视角”：吉姆·尼尔森；“慢性阻塞性肺疾病360与患者驱动研究网络”：约翰·沃尔什。
